ArticleJournal of controlled release : official journal of the Controlled Release Society2016

Oral delivery of anti-MDM2 inhibitor SP141-loaded FcRn-targeted nanoparticles to treat breast cancer and metastasis.

Jiang-Jiang Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.